Brief: Alterity Therapeutics Raises A$40M To Advance Ath434 Development In MSA
10/02/2025 01:17
Feb 10 (Reuters) - Alterity Therapeutics Ltd ATH.AX :
* ALTERITY RAISES A$40M TO ADVANCE ATH434 DEVELOPMENT IN MSA
* PLACEMENT WAS CONDUCTED AT A$0.011 PER SHARE
Further company coverage: ATH.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alterity Therapeutics
See all newsBrief: Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For Ath434 In Multiple System Atrophy
Brief: Alterity Therapeutics Receives Positive FDA Feedback On Ath434 Phase 3 Program
Brief: Alterity Therapeutics Says Julian Barbaczy Appointed Non-Exec Chair
Brief: Alterity Therapeutics Raises A$20.0 Million In Strategic Placement
Brief: Alterity Therapeutics Ltd Raises A$20 Million In Capital